- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: vilanterol
Total 112 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Japan, Poland, Romania, Russian Federation, Spain, Ukraine, Germany, Taiwan, Bulgaria, Hungary, France, Philippines, South Africa, Thailand, Israel, Korea, Republic of, Australia, Mexico, Slovakia, United... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, Russian Federation, Ukraine, Bulgaria, Estonia, Mexico, Korea, Republic of, Slovakia, Greece, China, Italy, Hungary, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Spain, United States, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Romania, Russian Federation, United States, Ukraine
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Estonia, Peru, Poland, France, Chile, Hungary, Italy, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUkraine, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, France, Germany, Russian Federation, Ukraine, Italy, Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Ukraine, Spain, South Africa, Italy
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Romania, Ukraine, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Ukraine, Estonia, Belgium, France, Sweden, Netherlands, Philippines, Denmark, Hungary, Norway, Slovakia
-
GlaxoSmithKlineParexelWithdrawn
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Ukraine, United States, Estonia, South Africa, Sweden, Norway, Russian Federation, Korea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Ukraine, Germany, Peru, Poland, France, Romania, Italy, Mexico
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Romania, Russian Federation, Ukraine, Chile, Sweden, Mexico, Netherlands, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Romania, Poland, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Romania, Russian Federation, Ukraine, Germany, Hungary, Bulgaria
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Chile, Romania, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Romania, Ukraine, United States, Chile, Greece, Peru
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, United States, Czechia, Russian Federation
-
GlaxoSmithKlineCompletedAsthmaGermany, Ukraine, United States, Peru, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Philippines, Thailand, Korea, Republic of, Norway
-
GlaxoSmithKlineCompletedAsthmaArgentina, Russian Federation, United States, Chile, Thailand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, Spain, Netherlands, Hungary, Denmark, Poland, Czechia
-
GlaxoSmithKlineCompleted
-
Queen's UniversityGlaxoSmithKlineCompleted
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveCzechia, Hungary
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveHungary, Slovakia
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineHammersmith Medicines ResearchCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Australia, United States, Germany, Chile, Korea, Republic of, Mexico, Canada, South Africa, Romania
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Korea, Republic of, Czech Republic
-
GlaxoSmithKlineCompletedAsthmaKorea, Republic of, China, Philippines
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedHZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsAsthmaUnited States, Argentina, Korea, Republic of, Netherlands, Philippines, Chile
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, Germany, New Zealand
-
GlaxoSmithKlineCompletedAsthmaUnited States